Cyclopharm Limited (ASX:CYC)
Cyclopharm Limited is an Australia-based company engaged in the manufacture and sale of medical equipment and radiopharmaceuticals, including associated research and development. It provides diagnostic imaging services specializing in lung health. The Company through its medical device and pharmaceutical products under the name of Technegas, which has become the industry in diagnostic functional lung imaging technology. It distributes its products in approximately 60 countries throughout the world with over 1500 nuclear medicine departments utilizing Technegas. The Company formed a joint venture with Alfred Health Solutions and Macquarie University Hospital to provide various imaging services on-site at the hospital. The Macquarie Medical Imaging (MMI) offers a range of diagnostic radiology, interventional radiology, nuclear medicine and molecular imaging services for inpatient and outpatients. Its Ultralute is a device that extends the useful life of Molybdenum-99 (Mo-99) generators.